C-reactive protein (CRP): understanding inflammation and its link to biological age
Biological Age Series — Biomarkers of physiological aging
C‑reactive protein (CRP) is one of the most commonly used biomarkers in clinical practice to objectively quantify inflammation. On its own, it doesn’t explain “what’s wrong,” but it does inform a cross-cutting biological signal: activation of the immune system and tissue inflammation. In a longevity approach, it’s a particularly useful indicator, because low‑grade inflammation is frequently associated with physiological aging and several long‑term health trajectories.[1–2]
Measure biological age with Medfuture
The Biological Age Profile (DNAm PhenoAge) aims to estimate biological age and contextualize prevention levers from a structured biological profile.
• DNAm PhenoAge overview page: View the page
• Book / Biological Age Profile: View the service
What is CRP?
C‑reactive protein (CRP) is an acute‑phase protein, produced mainly by the liver in response to inflammatory signals. Its value lies in its sensitivity: its concentration can rise quickly when an inflammatory process is active (infection, tissue inflammation, an inflammatory flare, etc.).[1]
CRP, inflammation, and physiological aging
In gerontology, the concept of inflamm‑aging describes a common tendency for low‑grade inflammation to increase with advancing age, influenced by immune, metabolic, and environmental mechanisms.[2] CRP does not replace clinical evaluation and does not pinpoint the source of inflammation, but it is a useful indicator for tracking the overall inflammatory signal over time.[1–2]
Why CRP is linked to biological age (PhenoAge / DNAm PhenoAge)
CRP and clinical PhenoAge
The Phenotypic Age (PhenoAge) model was developed using large population cohorts. It uses chronological age and nine clinical biomarkers — including CRP — selected for their ability to predict long‑term health outcomes (morbidity/mortality).[3]
In this framework, CRP contributes to the score by reflecting an important dimension of physiological aging: systemic inflammation. This is a statistical risk‑estimation model, not a diagnosis.[3]
DNAm PhenoAge and biological rationale
DNAm PhenoAge is an epigenetic measure developed to reflect a component of biological aging, linked to a phenotypic measure of aging. This conceptual link helps explain why inflammation and biomarkers like CRP are frequently discussed in the scientific ecosystem of “biological ages.”[4]
How to interpret CRP rigorously
Check the context of the blood draw
CRP is highly sensitive to acute situations. Before interpreting a result from a longevity perspective, the ideal is to document a baseline value during a stable period (no recent infection, inflammatory flare, or major physiological stress).[1]
Useful reference points (standard CRP)
In a healthy population, CRP is generally low: among healthy adult donors, a median of about 0.8 mg/L has been reported, and the 99th percentile value around 10 mg/L.[1] Conversely, during an acute inflammatory stimulus, CRP can rise very substantially (sometimes above several hundred mg/L).[1]
In practice, a persistent CRP above about 10 mg/L suggests a significant inflammatory response and warrants clinical evaluation and, often, repeat testing in a stable context.[1]
How to optimize CRP to support a more favorable biological age
The goal is not to “chase a number,” but to act on health determinants that, in the literature, are associated with lower CRP levels and more favorable risk profiles. The elements below are presented for educational purposes and should be adapted to the individual medical context.
Reduce excess body fat
A synthesis of the literature indicates that weight loss is associated with a decrease in CRP, supporting the idea that adiposity contributes to the systemic inflammatory signal.[7]
Build a structured exercise routine
A meta‑analysis reports an average reduction in CRP after exercise interventions, with variability depending on the populations and protocols.[8]
Improve diet quality
An umbrella review suggests that certain dietary patterns are associated with lower CRP levels, with evidence quality varying across studies.[11]
Optimize sleep
Meta‑analyses have described associations between sleep disturbances, extreme sleep durations, and inflammatory markers — including CRP — across different contexts.[9]
Reduce tobacco exposure
Smoking is associated with higher CRP levels. Some longitudinal data suggest improvements may not be immediate after quitting, reinforcing the value of tracking trends over time rather than relying on a single reading.[10]
Don’t confuse a biomarker with causality
CRP is a useful marker, but it is not sufficient to explain a health trajectory. Some trials targeting inflammation have shown clinical benefits in specific contexts, underscoring the biological importance of inflammation — without making CRP, by itself, a causal or diagnostic tool.[6]
FAQ — CRP and biological age
Does CRP indicate where the inflammation is located?
No. CRP reflects an overall inflammatory signal. It does not specify the location or the cause; interpretation must be contextualized with symptoms, clinical examination, and other tests.[1]
What CRP can be considered “within the normal range”?
In a healthy population, CRP is generally low. Data in healthy adult donors report a median around 0.8 mg/L and a 99th percentile close to 10 mg/L.[1]
Should a CRP above 10 mg/L be rechecked?
Often, yes — especially if the context does not clearly suggest an acute event. A persistent CRP above about 10 mg/L suggests a significant inflammatory response and warrants clinical evaluation and, frequently, repeat testing during a stable period.[1]
Why is CRP relevant for biological age?
CRP is one of the clinical biomarkers used in PhenoAge because it reflects an important dimension of physiological aging: systemic inflammation. The value is mainly in a structured, longitudinal reading rather than an isolated result.[3–4]
Important note : This content is for informational purposes and does not replace medical advice. For a personalized interpretation, a healthcare professional must consider the clinical context, symptoms, and the full set of laboratory results.
Next steps in the series
C‑reactive protein (CRP) illustrates the central role of inflammation in physiological aging. It is often a first entry point to understand how cross‑cutting biological processes can influence biological age.
The next articles in the Biological Age Series — Biomarkers of physiological aging will cover albumin, creatinine, glucose, and other biomarkers integrated into biological age models used in research. Each biomarker will be analyzed individually, with a perspective of understanding, prevention, and longitudinal monitoring.
Scientific references
- Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812. doi: 10.1172/JCI18921.
- Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254. doi: 10.1111/j.1749-6632.2000.tb06651.x.
- Levine ME, Lu AT, Quach A, et al. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES. PLOS Med. 2018;15(12):e1002718. doi: 10.1371/journal.pmed.1002718.
- Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573–591. doi: 10.18632/aging.101414.
- Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–140. doi: 10.1016/S0140-6736(09)61717-7.
- Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377:1119–1131. doi: 10.1056/NEJMoa1707914.
- Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med. 2007;167(1):31–39. doi: 10.1001/archinte.167.1.31.
- Fedewa MV, Hathaway ED, Ward-Ritacco CL. Effect of exercise training on C reactive protein: a systematic review and meta-analysis. Br J Sports Med. 2017;51(8):670–676. doi: 10.1136/bjsports-2016-095999.
- Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: a systematic review and meta-analysis. Biol Psychiatry. 2016;80(1):40–52. doi: 10.1016/j.biopsych.2015.05.014.
- Gallus S, Lugo A, Suatoni P, et al. Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels… Sci Rep. 2018;8:12908. doi: 10.1038/s41598-018-29867-9.
- Tran DQ, Di KN, Chi VTQ, Nguyen HTHN. Evaluating the effects of dietary patterns on circulating C-reactive protein levels… Br J Nutr. 2024;132(6):783–793. doi: 10.1017/S0007114524001648.
Access the Biological Age Profile
For those who want to go further, Medfuture offers a Biological Age Profile based on the DNAm PhenoAge approach, which estimates biological age and situates different biomarkers within a structured framework.